Mantra Bio
United States · $39.0M raised
- Business Model
- B2B
- Total Funding
- $39.0M
- Last Round
- $9.0M Series AJan 2023
- Rounds
- 3
About
Biotechnology company developing targeted exosome-based therapeutics using its proprietary REVEAL platform.
Summary
Mantra Bio is a Biotech company based in United States. It has raised $39.0M in total across 3 rounds, most recently a $9.0M Series A round in Jan 2023. Investors include 8VC, Viking Global and Allen & Company.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...